Cargando…

High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma

COL17A1 (collagen type XVII alpha 1 chain) is known to be upregulated and has a prognostic role in many malignancies, as well as contributing to cell proliferation, apoptosis, and invasion. However, little knowledge is available on the expression and prognostic value of COL17A1 in pancreatic adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Feiyu, Li, Duguang, Xin, Zechang, Du, Yan, Wang, Xiaodong, Xu, Peng, Li, Zhennan, Qian, Jianjun, Yao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758145/ https://www.ncbi.nlm.nih.gov/pubmed/33381179 http://dx.doi.org/10.1155/2020/8868245

Ejemplares similares

Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2021)

Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis
por: Liu, Peng, et al.
Publicado: (2021)

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
por: Owusu-Ansah, Kwabena Gyabaah, et al.
Publicado: (2019)

Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2021)

Distal pancreatectomy with en bloc celiac axis resection does not improve the R0 rate or median survival time of patients with locally advanced pancreatic cancer: a systematic review and meta-analysis
por: Feng, Qingbo, et al.
Publicado: (2020)

Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis
por: Zhang, Lihua, et al.
Publicado: (2020)

SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis
por: Ma, Qiang, et al.
Publicado: (2017)

Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)

Prognostic value of COL6A3 in pancreatic adenocarcinoma
por: Svoronos, Christos, et al.
Publicado: (2020)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

High expression of COL10A1 is associated with poor prognosis in colorectal cancer
por: Huang, Haipeng, et al.
Publicado: (2018)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma
por: Liu, Na, et al.
Publicado: (2021)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma
por: Yuan, Xia, et al.
Publicado: (2023)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
por: Huang, Xinyang, et al.
Publicado: (2022)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)

High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
por: Li, He, et al.
Publicado: (2020)

Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis
por: Izumi, Hideki, et al.
Publicado: (2015)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

High expression COL10A1 promotes breast cancer progression and predicts poor prognosis
por: Zhou, Weijian, et al.
Publicado: (2022)

KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma
por: Li, Yuexian, et al.
Publicado: (2021)

Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis
por: Zhou, Jun, et al.
Publicado: (2019)

Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses
por: Li, Yang, et al.
Publicado: (2020)

COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma
por: Xu, Qiaodong, et al.
Publicado: (2023)

Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer
por: Lin, Gen, et al.
Publicado: (2018)

High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
por: Huo, Yanmiao, et al.
Publicado: (2015)

Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer
por: Liu, Qi, et al.
Publicado: (2022)

Low expression of tRF‐Pro‐CGG predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Li, Jun, et al.
Publicado: (2021)

COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
por: Wang, Lihuai, et al.
Publicado: (2022)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
por: Zong, Meijuan, et al.
Publicado: (2011)

Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer
por: Huang, Wen-liang, et al.
Publicado: (2022)

High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Han, Hailin, et al.
Publicado: (2018)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9c8bbof2m76eramcpc4028te6m